KeyBank National Association
ADPT icon

KeyBank National Association’s Adaptive Biotechnologies ADPT Stock Holding History

KeyBank National Association’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Buy
10,340
+87
+0.8% +$1.33K ﹤0.01% 1239
2026
Q1 		$142K Sell
10,253
-7,713
-43% -$123K ﹤0.01% 1216
2025
Q4 		$292K Buy
17,966
+7,604
+73% +$124K ﹤0.01% 1034
2025
Q3 		$155K Buy
+10,362
New +$126K ﹤0.01% 1154

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

KeyBank National Association's ADPT Position: Q2 2026 in Review

KeyBank National Association increased its Adaptive Biotechnologies (ADPT) stake by 0.85% in Q2 2026, buying an estimated $1.33K and bringing the position to 10,340 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #1239.

KeyBank National Association first reported a position in ADPT in Q3 2025 and has held it in 4 quarters since. The position peaked at $292K in Q4 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • KeyBank National Association held 10,340 shares of Adaptive Biotechnologies worth $222K as of Q2 2026.
  • KeyBank National Association bought 87 Adaptive Biotechnologies shares in Q2 2026, an estimated $1.33K.
  • Adaptive Biotechnologies made up ﹤0.01% of KeyBank National Association's portfolio in Q2 2026, its #1239 holding.
  • KeyBank National Association first reported a position in Adaptive Biotechnologies in Q3 2025 and has held it in 4 quarters since.
  • KeyBank National Association's Adaptive Biotechnologies position peaked at $292K in Q4 2025.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.